Summary
The product Winstrol Stanozolol, submitted by the manufacturer Vulkan Pharma (vulkanpharma@proton.me), underwent qualitative and quantitative analysis. The batch information provided is LOT: 6PT91V, and the analysis detected a concentration of 10.10 mg of Stanozolol.
The analysis was conducted on 13 November 2024, following the sample receipt on 5 November 2024.
Detailed Report
Product Information
- Manufacturer: Vulkan Pharmaceuticals
- Product Name: Winstrol Stanozolol
- Active Ingredient: Stanozolol
- Batch Number: LOT: 6PT91V
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Processing and Analysis
- Task Number: #52515
- Testing Ordered: 29 October 2024
- Sample Received: 5 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Vulkan Pharmaceuticals (Manufacturer)
- Analysis Paid For By: Vulkan Pharmaceuticals (Manufacturer)
Testing Results
- Specification: 10 mg/ml (typical label claim)
- Measured Concentration: 10.10 mg/ml
- Accuracy: 101.00% (1.00% below the typical label claim)
- Variance: 1.00%
Verification Details
- Verification URL: https://janoshik.com/tests/52515_7TJQW92GXW1Y
Evaluation of Manufacturer-Submitted Testing
The test confirmed the presence of 10.10 mg of Stanozolol. The concentration appears to align with expected levels for this type of product formulation.
Conclusion
This report supports the presence and appropriate concentration of the compound Stanozolol.
Disclaimer
This report is provided for educational and harm reduction purposes. Product submissions may involve inherent biases, and independent verification is recommended for critical evaluations.
